Novocure’s stock surges after positive results in brain-cancer trial

Novocure Ltd.’s stock soared 15% Wednesday after the company announced positive results from a late-stage trial of a medtech device to treat patients with lung cancer that has spread to their brains.

Previous post The bitcoin halving is near. Here’s one thing for investors to keep in mind.
Next post Discover CEO resigns to take top job at Ally Financial